Loading…
Reported covered position: Deputy Assistant Secretary for Legislation, Senior Advisor/Congressional Liaison-HHS; Legislative Director,Senior Legislative Assistant,Legislative Assistant,Legislative Correspondent-Cong. Mark Pocan, D-WI; Staff Assistant-Cong. Tammy Baldwin, D-WI
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · 3T
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Source: Senate LDA
| BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) |
| 12 |
| 2023–2026 |
| CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | 12 | 2023–2026 |
| CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 12 | 2023–2026 |
| CVS HEALTH | 12 | 2023–2026 |
| REFLEXION MEDICAL | 12 | 2023–2026 |
| UNUM GROUP | 12 | 2023–2026 |
| ABBOTT LABORATORIES | 11 | 2024–2026 |
| DIALYSIS PATIENT CITIZENS | 11 | 2024–2026 |
| PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) | 10 | 2024–2026 |
| RESEARCH!AMERICA | 9 | 2023–2025 |
| Hims & Hers Health, Inc. | 8 | 2025–2026 |
| MCKESSON CORPORATION | 8 | 2025–2026 |
| THE COCA-COLA COMPANY | 7 | 2025–2026 |
| CLEAN SLATE INITIATIVE, INC. (CSI) | 6 | 2024–2025 |
| UNITED WAY WORLDWIDE (UWW) | 6 | 2025–2026 |
| AMERICAN PUBLIC TRANSPORTATION ASSOCIATION (APTA) | 5 | 2023–2024 |
| ECKERD CONNECTS | 4 | 2026 |
| HEARTFLOW, INC. | 4 | 2026 |
| PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) | 4 | 2026 |
| ANTHROPIC PBC | 3 | 2026 |
| PUBLIC HEALTH INSTITUTE (PHI) | 3 | 2026 |
| INTERNATIONAL FRANCHISE ASSOCIATION (IFA) | 2 | 2025 |
| VANTIVE | 2 | 2026 |
| HIGHMARK INC. | 1 | 2026 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION | 1 | 2023 |
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
Issues related to health care and vital organ therapy. Issues related to H.R. 8319, KIDNEY Remote Monitoring Act.
HELP Act of 2026
Client: UNITED WAY WORLDWIDE (UWW) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
HELP Act of 2026
Client: UNITED WAY WORLDWIDE (UWW) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: RESEARCH!AMERICA · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Helping Our Heroes Act
Client: AMERICAN KRATOM ASSOCIATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to H.R. 5905, Federal Kratom Consumer Protection Act, and the Fiscal Year 2026 Agriculture Appropriations bills.
Helping Our Heroes Act
Client: AMERICAN KRATOM ASSOCIATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to H.R. 5905, Federal Kratom Consumer Protection Act, and the Fiscal Year 2026 Agriculture Appropriations bills. Issues related to consumer information access.
Helping Our Heroes Act
Client: AMERICAN KRATOM ASSOCIATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to H.R. 5905, Federal Kratom Consumer Protection Act, and the Fiscal Year 2026 Agriculture Appropriations bills.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Restore Protections for Dialysis Patients Act
Client: DIALYSIS PATIENT CITIZENS · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R.1691, The Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to appropriate reimbursement for radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R.1691, The Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to appropriate reimbursement for radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy including H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, the Equitable Community Access to Pharmacist Services Act.
Saving Access to Laboratory Services Act
Client: AMERICAN CLINICAL LABORATORY ASSOCIATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
General issues related to clinical laboratories and reimbursement for clinical laboratory services. Issues related S.1000/H.R.2377, Saving Access to Laboratory Services Act. Issues related to coding for laboratory services. Issues related to price transparency related to clinical laboratory services.
2026 · third_quarter · Q3
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE (UWW) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
Issues related to the Fiscal Year 2027 appropriations process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTHROPIC, PBC via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to artificial intelligence in the Fiscal Year 2027 Appropriations bills.
Issues relating to safety, development, economic impact, and use of artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICANS FOR RESPONSIBLE INNOVATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to artificial intelligence and data center usage in the Fiscal Year 2027 Appropriations bills.
Issues relating to safety, development, economic impact, and use of artificial intelligence. Issues related to biosecurity. Issues related to data centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to health care and vital organ therapy. Issues related to H.R. 8319, KIDNEY Remote Monitoring Act.
Filing targets: HOUSE OF REPRESENTATIVES
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to supplemental health insurance and Family and Medical Leave.
Issues related to paid leave and retirement savings.
Filing targets: General Services Administration (GSA), SENATE
DIALYSIS PATIENT CITIZENS via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN KRATOM ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act. Issues related to the Controlled Substances Act (Public Law 91-513).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Issues related to health insurance coverage. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUBLIC HEALTH INSTITUTE (PHI) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to federal public health programs.
Issues related to federal funding of public health programs.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ECKERD CONNECTS via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the Job Corps Program and workforce development.
Issues related to workforce development and the shipbuilding industry in the Fiscal Year 2027 National Defense Authorization Act.
Issues related to early education programming.
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to pharmaceutical supply chains and patient access.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. Issues related to diagnostic services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to ingredients.
Issues related to Supplemental Nutrition Assistance Program and food safety.
Filing targets: HOUSE OF REPRESENTATIVES
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to blood cancer research for adult and pediatric populations. Issues related to health coverage and patient access to care.
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency funding for medical and cancer research. Issues related to pediatric drug development. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to tariffs and generic pharmaceuticals.
Issues related to generic pharmaceuticals and drug shortages.
Filing targets: Executive Office of the President (EOP), SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices. Issues related to FDA user fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to clinical laboratories and payment for clinical laboratory services.
Issues related to clinical laboratories and payment for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the supply of infant formula and nutrition.
Issues related to medical device reimbursement, cybersecurity, and supply chains. Issues related to diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · RR
Issues related to health care and vital organ therapy.
PUBLIC HEALTH INSTITUTE (PHI) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to federal funding of public health programs.
Issues related to federal funding of public health programs.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · RR
Issues related to health insurance and coverage.
Issues related to health insurance and coverage.
AMERICANS FOR RESPONSIBLE INNOVATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to artificial intelligence and data center usage in the Fiscal Year 2027 Appropriations bills.
Issues related to biosecurity.
Issues relating to safety, development, economic impact, and use of artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTHROPIC, PBC via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to artificial intelligence in the Fiscal Year 2027 Appropriations bills.
Issues relating to safety, development, economic impact, and use of artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE (UWW) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
Issues related to the Fiscal Year 2027 appropriations process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to supplemental health insurance and Family and Medical Leave.
Issues related to paid leave and retirement savings.
Filing targets: General Services Administration (GSA), SENATE
AMERICAN KRATOM ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act. Issues related to the Controlled Substances Act (Public Law 91-513).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to pharmaceutical supply chains and patient access.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ECKERD CONNECTS via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the Fiscal Year 2027 Labor-HHS Appropriations bill.
Issues related to the Job Corps Program and workforce development.
Issues related to workforce development and the shipbuilding industry in the Fiscal Year 2027 National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIALYSIS PATIENT CITIZENS via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Supplemental Nutrition Assistance Program and food safety.
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency funding for medical and cancer research. Issues related to pediatric drug development.
Issues related to blood cancer research for adult and pediatric populations. Issues related to health coverage and patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to tariffs and generic pharmaceuticals.
Issues related to generic pharmaceuticals and drug shortages.
Filing targets: Executive Office of the President (EOP), SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to health insurance coverage. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to clinical laboratories and payment for clinical laboratory services.
Issues related to clinical laboratories and payment for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. Issues related to diagnostic services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the supply of infant formula and nutrition.
Issues related to medical device reimbursement. Issues related to diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUBLIC HEALTH INSTITUTE (PHI) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · RR
Issues related to public health, nutrition, substance abuse disorders, cancer prevention, and rural health.
UNITED WAY WORLDWIDE (UWW) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
Issues related to the 211 network and the Human-Services Emergency Logistic Program (HELP) Act.
Issues related to the Fiscal Years 2026 and 2027 appropriations processes. Issues related to the lapse in federal government funding, including grant programs at the U.S. Department of Homeland Security.
ANTHROPIC, PBC via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to artificial intelligence in the Fiscal Year 2027 Appropriations bills.
Issues relating to safety, development and use of artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICANS FOR RESPONSIBLE INNOVATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to artificial intelligence, data center usage and biosecurity in the Fiscal Year 2027 Appropriations bills.
Issues related to biosecurity.
Issues relating to safety, development and use of artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the pharmaceutical supply chain and drug shortages.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Issues related to pharmaceutical supply chains and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ECKERD CONNECTS via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the Fiscal Year 2027 Labor-HHS Appropriations bill.
Issues related to workforce development and the shipbuilding industry in the Fiscal Year 2027 National Defense Authorization Act.
Issues related to the Job Corps Program and workforce development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Supplemental Nutrition Assistance Program and food safety.
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to supplemental health insurance and Family and Medical Leave.
Issues related to paid leave and retirement savings.
Filing targets: General Services Administration (GSA), Treasury, Dept of
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIALYSIS PATIENT CITIZENS via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to generic pharmaceuticals and drug shortages.
Issues related to tariffs and generic pharmaceuticals.
Filing targets: SENATE
AMERICAN KRATOM ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act. Issues related to the Controlled Substances Act (Public Law 91-513).
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to health insurance coverage.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to clinical laboratories and reimbursement for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to medical device reimbursement. Issues related to diagnostic testing.
Issues related to the supply of infant formula and nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · RR
Issues related to Medicare reimbursement.
Issues related to Medicare reimbursement.
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · RR
Issues related to pharmaceutical compounding.
ECKERD CONNECTS via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · RR
Issues related to workforce development programs, funding, and Job Corps.
Issues related to workforce development programs, funding, and Job Corps.
UNITED WAY WORLDWIDE (UWW) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the 211 network and the Human-Services Emergency Logistic Program (HELP) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to paid leave and retirement savings.
Issues related to supplemental health insurance and Family and Medical Leave.
Filing targets: General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE
RESEARCH!AMERICA via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General education about federal health and science research. Issues related to federal research policies including rare and neglected tropical diseases.
Issues related to the Fiscal Year 2026 appropriations process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the pharmaceutical supply chain and drug shortages.
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIALYSIS PATIENT CITIZENS via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEAN SLATE INITIATIVE, INC. (CSI) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to automatic criminal record clearance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to Supplemental Nutrition Assistance Program and food safety.
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICANS FOR RESPONSIBLE INNOVATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues relating to safety, development and use of artificial intelligence.
Issues relating to safety, development and use of artificial intelligence.
Issues related to artificial intelligence and the Fiscal Year 2026 Commerce-Justice-State Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to generic pharmaceuticals and drug shortages.
Issues related to tariffs and generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN KRATOM ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to health insurance coverage.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to clinical laboratories and reimbursement for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the supply of infant formula and nutrition.
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Fiscal Year 2027 Labor-HHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Fiscal Year 2026 Agriculture-Food and Drug Administration Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE